Phosphodiesterase 4 (PDE4) Inhibitor in Atopic Dermatitis: Impact of Nanocrisaborole on Biopharmaceutical Performance and Treatment Outcomes

Md. Shoaib Alam, Sheikh Shafiq-un-Nabi, Veeraraghavan Gayathri, Saba Maanvizhi, Javed Ahmad, Arif Ansari, Ayesha Akhtar

Open source

DOI
10.2174/0113895575414838251205172531
Published
2026-09
Container
Mini-Reviews in Medicinal Chemistry
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113895575414838251205172531,
  title = {Phosphodiesterase 4 (PDE4) Inhibitor in Atopic Dermatitis: Impact of Nanocrisaborole on Biopharmaceutical Performance and Treatment Outcomes},
  author = {Md. Shoaib Alam and Sheikh Shafiq-un-Nabi and Veeraraghavan Gayathri and Saba Maanvizhi and Javed Ahmad and Arif Ansari and Ayesha Akhtar},
  year = {2026},
  journal = {Mini-Reviews in Medicinal Chemistry},
  doi = {10.2174/0113895575414838251205172531},
  url = {https://doi.org/10.2174/0113895575414838251205172531}
}

RIS

TY  - JOUR
TI  - Phosphodiesterase 4 (PDE4) Inhibitor in Atopic Dermatitis: Impact of Nanocrisaborole on Biopharmaceutical Performance and Treatment Outcomes
AU  - Md. Shoaib Alam
AU  - Sheikh Shafiq-un-Nabi
AU  - Veeraraghavan Gayathri
AU  - Saba Maanvizhi
AU  - Javed Ahmad
AU  - Arif Ansari
AU  - Ayesha Akhtar
PY  - 2026
JO  - Mini-Reviews in Medicinal Chemistry
DO  - 10.2174/0113895575414838251205172531
UR  - https://doi.org/10.2174/0113895575414838251205172531
ER  - 

APA

Alam, M. S., Shafiq-un-Nabi, S., Gayathri, V., Maanvizhi, S., Ahmad, J., Ansari, A., & Akhtar, A. (2026). Phosphodiesterase 4 (PDE4) Inhibitor in Atopic Dermatitis: Impact of Nanocrisaborole on Biopharmaceutical Performance and Treatment Outcomes. Mini-Reviews in Medicinal Chemistry. https://doi.org/10.2174/0113895575414838251205172531

Source records